PepTx, Inc. is an early stage pharmaceutical company that discovers and develops novel peptides, partial peptide mimetics, and related small molecule therapeutics. By applying principals of structural proteomics to the pharmacology of drug discovery over the past three years, we have discovered a number of therapeutic peptides and peptidomemetic drug leads in the areas of oncology and anti-infectives.